Amicus Therapeutics
FOLD
#3904
Rank
NZ$5.26 B
Marketcap
NZ$17.06
Share price
0.61%
Change (1 day)
1.70%
Change (1 year)

Amicus Therapeutics (FOLD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$1.10 Billion

According to Amicus Therapeutics 's latest financial reports the company's total liabilities are NZ$1.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Amicus Therapeutics - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$1.04 B7.28%
2023-12-31NZ$0.97 B3.17%
2022-12-31NZ$0.94 B8.19%
2021-12-31NZ$0.87 B5.22%
2020-12-31NZ$0.83 B49.86%
2019-12-31NZ$0.55 B-16.72%
2018-12-31NZ$0.66 B72.63%
2017-12-31NZ$0.38 B-60.48%
2016-12-31NZ$0.97 B19.28%
2015-12-31NZ$0.81 B630.97%
2014-12-31NZ$0.11 B12.54%
2013-12-31NZ$99.55 M100.4%
2012-12-31NZ$49.67 M-3.56%
2011-12-31NZ$51.51 M-16.54%
2010-12-31NZ$61.72 M231.17%
2009-12-31NZ$18.63 M-81.26%
2008-12-31NZ$99.48 M19.44%
2007-12-31NZ$83.29 M-57.22%
2006-12-31NZ$0.19 B106.31%
2005-12-31NZ$94.36 M
2003-12-31NZ$8.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
NZ$19.01 B 1,623.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.69 B 144.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.40 B 27.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$105.94 B 9,499.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
NZ$0.14 B-86.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$93.07 B 8,333.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark